Literature DB >> 9655178

Association of myeloperoxidase with heparin: oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme.

E M Daphna1, S Michaela, P Eynat, A Irit, S Rimon.   

Abstract

Chromatography of human myeloperoxidase (MPO) on a heparin-agarose column demonstrated a tight association of the protein with the resin. The electrophoretic mobility of mixtures of MPO and heparin in polyacrylamide gels under nondenaturing conditions was consistent with a strong interaction of the cationic enzyme with the polyanionic polysaccharide. Purified MPO prebound to bovine aorta endothelial cells (BAEC) and supplemented with hydrogen peroxide dose- and time-dependently abrogated the interaction of coagulation factor IX (FIX) with factor IX-binding protein (FIXBP) on the surface of BAEC reflecting oxidative modification of the binding protein. This inactivation of FIXBP required the presence of chloride implicating hypochlorite in the reaction. Hypochlorite and activated neutrophils exerted a similar effect. The oxidative modification of FIXBP was only partially dependent on the addition of hydrogen peroxide and was abolished by exogenous heparin which displaced MPO from the cell surface, emphasizing the functional differences between cell-bound and free enzyme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655178     DOI: 10.1023/a:1006848730927

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  30 in total

1.  Identification of a factor IX/IXa binding protein on the endothelial cell surface.

Authors:  S Rimon; R Melamed; N Savion; T Scott; P P Nawroth; D M Stern
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

2.  Protein iodination with solid state lactoperoxidase.

Authors:  G S David; R A Reisfeld
Journal:  Biochemistry       Date:  1974-02-26       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.

Authors:  P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

5.  Selection and characterization of bovine aortic endothelial cells.

Authors:  S M Schwartz
Journal:  In Vitro       Date:  1978-12

Review 6.  Active oxygen species and the functions of phagocytic leukocytes.

Authors:  J A Badwey; M L Karnovsky
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

7.  New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system.

Authors:  R J Johnson; W G Couser; E Y Chi; S Adler; S J Klebanoff
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

8.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

9.  Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages.

Authors:  J W Heinecke; W Li; H L Daehnke; J A Goldstein
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

10.  Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan.

Authors:  J A Marcum; D H Atha; L M Fritze; P Nawroth; D Stern; R D Rosenberg
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  13 in total

Review 1.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

2.  Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.

Authors:  S Baldus; J P Eiserich; A Mani; L Castro; M Figueroa; P Chumley; W Ma; A Tousson; C R White; D C Bullard; M L Brennan; A J Lusis; K P Moore; B A Freeman
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  Oxidation of heparan sulphate by hypochlorite: role of N-chloro derivatives and dichloramine-dependent fragmentation.

Authors:  Martin D Rees; David I Pattison; Michael J Davies
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

4.  Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.

Authors:  Alan A Woods; Stuart M Linton; Michael J Davies
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

5.  Activated neutrophils oxidize extracellular proteins of endothelial cells in culture: effect of nitric oxide donors.

Authors:  Grzegorz A Czapski; Diana Avram; Dmitri V Sakharov; Karel W A Wirtz; Joanna B Strosznajder; Everard H W Pap
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

6.  Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates.

Authors:  Martin D Rees; Clare L Hawkins; Michael J Davies
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

7.  Fragmentation of extracellular matrix by hypochlorous acid.

Authors:  Alan A Woods; Michael J Davies
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

8.  Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.

Authors:  Volker Rudolph; Tanja K Rudolph; Francisco J Schopfer; Gustavo Bonacci; Denise Lau; Katalin Szöcs; Anna Klinke; Thomas Meinertz; Bruce A Freeman; Stephan Baldus
Journal:  J Pharmacol Exp Ther       Date:  2008-08-13       Impact factor: 4.030

9.  Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention.

Authors:  Michael J Davies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

Review 10.  Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies.

Authors:  Cédric Delporte; Pierre Van Antwerpen; Luc Vanhamme; Thierry Roumeguère; Karim Zouaoui Boudjeltia
Journal:  Mediators Inflamm       Date:  2013-07-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.